Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection

PLoS Pathogens

Volumn 13, Issue 11, 2017, Pages

  Turner, Lucien H ^a   Kinder, Jeremy M ^a   Wilburn, Adrienne ^a,b   D’Mello, Rahul J ^a   Braunlin, Makayla R ^a   Jiang, Tony T ^a,b   Pham, Giang ^a   Way, Sing Sing ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; STAT2 PROTEIN; TUMOR NECROSIS FACTOR; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; ASYMPTOMATIC INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRAUTERINE INFECTION; MALE; MOUSE; NONHUMAN; PREGNANCY; REINFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VIRUS LOAD; VIRUS NEUTRALIZATION; ZIKA FEVER; ZIKA VIRUS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; HUMAN; MIXED INFECTION; NEWBORN; PREGNANCY COMPLICATION; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ASYMPTOMATIC INFECTIONS; COINFECTION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT, NEWBORN; MICE, INBRED BALB C; MICE, INBRED C57BL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIKA VIRUS INFECTION;

EID: 85036519204     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006684     Document Type: Article

References (78)

1. Fauci AS, Morens DM, Zika Virus in the Americas—Yet Another Arbovirus Threat. N Engl J Med. 2016;374(7):601–4. doi: 10.1056/NEJMp1600297 26761185.
2. Lazear HM, Diamond MS, Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere. J Virol. 2016;90(10):4864–75. doi: 10.1128/JVI.00252-16 26962217
3. Coyne CB, Lazear HM, Zika virus—reigniting the TORCH. Nat Rev Microbiol. 2016;14(11):707–15. doi: 10.1038/nrmicro.2016.125 27573577.
4. Miner JJ, Diamond MS, Zika Virus Pathogenesis and Tissue Tropism. Cell Host Microbe. 2017;21(2):134–42. doi: 10.1016/j.chom.2017.01.004 28182948
5. Brasil P, Pereira JP, Jr.Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro. N Engl J Med. 2016;375(24):2321–34. doi: 10.1056/NEJMoa1602412 26943629.
6. Martines RB, Bhatnagar J, Keating MK, Silva-Flannery L, Muehlenbachs A, Gary J, et al. Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses—Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(6):159–60. doi: 10.15585/mmwr.mm6506e1 26890059.
7. Mlakar J, Korva M, Tul N, Popovic M, Poljsak-Prijatelj M, Mraz J, et al. Zika Virus Associated with Microcephaly. N Engl J Med. 2016;374(10):951–8. doi: 10.1056/NEJMoa1600651 26862926.
8. Ventura CV, Maia M, Bravo-Filho V, Gois AL, Belfort R, JrZika virus in Brazil and macular atrophy in a child with microcephaly. Lancet. 2016;387(10015):228. doi: 10.1016/S0140-6736(16)00006-4 26775125.
9. Pacheco O, Beltran M, Nelson CA, Valencia D, Tolosa N, Farr SL, et al. Zika Virus Disease in Colombia—Preliminary Report. N Engl J Med. 2016. doi: 10.1056/NEJMoa1604037 27305043.
10. Musso D, Gubler DJ, Zika Virus. Clin Microbiol Rev. 2016;29(3):487–524. doi: 10.1128/CMR.00072-15 27029595
11. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360(24):2536–43. doi: 10.1056/NEJMoa0805715 19516034.
12. Aubry M, Teissier A, Huart M, Merceron S, Vanhomwegen J, Roche C, et al. Zika Virus Seroprevalence, French Polynesia, 2014–2015. Emerg Infect Dis. 2017;23(4). doi: 10.3201/eid2304.161549 28084987.
13. Abbink P, Larocca RA, De La Barrera RA, Bricault CA, Moseley ET, Boyd M, et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science. 2016. doi: 10.1126/science.aah6157 27492477.
14. Shan C, Muruato AE, Nunes BTD, Luo H, Xie X, Medeiros DBA, et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat Med. 2017. doi: 10.1038/nm.4322 28394328.
15. Larocca RA, Abbink P, Peron JP, Zanotto PM, Iampietro MJ, Badamchi-Zadeh A, et al. Vaccine protection against Zika virus from Brazil. Nature. 2016;536(7617):474–8. doi: 10.1038/nature18952 27355570
16. Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017. doi: 10.1038/nature21428 28151488.
17. Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, et al. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. 2017. doi: 10.1016/j.cell.2017.02.017 28222903.
18. Dowd KA, Ko SY, Morabito KM, Yang ES, Pelc RS, DeMaso CR, et al. Rapid development of a DNA vaccine for Zika virus. Science. 2016;354(6309):237–40. doi: 10.1126/science.aai9137 27708058.
19. Sumathy K, Kulkarni B, Gondu RK, Ponnuru SK, Bonguram N, Eligeti R, et al. Protective efficacy of Zika vaccine in AG129 mouse model. Sci Rep. 2017;7:46375. Epub 2017/04/13. doi: 10.1038/srep46375 28401907
20. Richner JM, Jagger BW, Shan C, Fontes CR, Dowd KA, Cao B, et al. Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease. Cell. 2017;170(2):273–83 e12. doi: 10.1016/j.cell.2017.06.040 28708997
21. Shan C, Muruato AE, Jagger BW, Richner J, Nunes BTD, Medeiros DBA, et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 2017;8(1):676. doi: 10.1038/s41467-017-00737-8 28939807
22. Boue A, Nicolas A, Montagnon B, Reinfection with rubella in pregnant women. Lancet. 1971;1(7712):1251–3. 4104713.
23. Harcourt GC, Best JM, Banatvala JE, Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. J Infect Dis. 1980;142(2):145–55. 7410897.
24. Lamont RF, Sobel JD, Carrington D, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, et al. Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG. 2011;118(10):1155–62. doi: 10.1111/j.1471-0528.2011.02983.x 21585641
25. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ, Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001;344(18):1366–71. doi: 10.1056/NEJM200105033441804 11333993.
26. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303(15):1517–25. doi: 10.1001/jama.2010.479 20407061.
27. Clark DR, Chaturvedi V, Kinder JM, Jiang TT, Xin L, Ertelt JM, et al. Perinatal Listeria monocytogenes susceptibility despite preconceptual priming and maintenance of pathogen-specific CD8(+) T cells during pregnancy. Cell Mol Immunol. 2014;11(6):595–605. Epub 2014/09/23. doi: 10.1038/cmi.2014.84 25242275
28. McGregor IA, Epidemiology, malaria and pregnancy. Am J Trop Med Hyg. 1984;33(4):517–25. 6383091.
29. Rogerson SJ, Malaria in pregnancy and the newborn. Adv Exp Med Biol. 2010;659:139–52. doi: 10.1007/978-1-4419-0981-7_12 20204762.
30. Hammon WM, Sather GE, Immunity of hamsters to West Nile and Murray Valley viruses following immunization with St. Louis and Japanese B. Proc Soc Exp Biol Med. 1956;91(3):521–4. 13322987.
31. Lobigs M, Diamond MS, Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex. Expert Rev Vaccines. 2012;11(2):177–87. doi: 10.1586/erv.11.180 22309667
32. Price WH, Thind IS, O'Leary W, el Dadah AH, A protective mechanism induced by live group B arboviruses against heterologous group B arboviruses independent of serum neutralizing antibodies or interferon. Am J Epidemiol. 1967;86(1):11–27. 4378109.
33. O'Leary DR, Kuhn S, Kniss KL, Hinckley AF, Rasmussen SA, Pape WJ, et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003–2004. Pediatrics. 2006;117(3):e537–45. doi: 10.1542/peds.2005-2024 16510632.
34. Lazear HM, Govero J, Smith AM, Platt DJ, Fernandez E, Miner JJ, et al. A Mouse Model of Zika Virus Pathogenesis. Cell Host Microbe. 2016;19(5):720–30. doi: 10.1016/j.chom.2016.03.010 27066744
35. Miner JJ, Cao B, Govero J, Smith AM, Fernandez E, Cabrera OH, et al. Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise. Cell. 2016;165(5):1081–91. doi: 10.1016/j.cell.2016.05.008 27180225
36. Grant A, Ponia SS, Tripathi S, Balasubramaniam V, Miorin L, Sourisseau M, et al. Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host Microbe. 2016;19(6):882–90. doi: 10.1016/j.chom.2016.05.009 27212660
37. Kumar A, Hou S, Airo AM, Limonta D, Mancinelli V, Branton W, et al. Zika virus inhibits type-I interferon production and downstream signaling. EMBO Rep. 2016;17(12):1766–75. doi: 10.15252/embr.201642627 27797853
38. Aliota MT, Dudley DM, Newman CM, Mohr EL, Gellerup DD, Breitbach ME, et al. Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques. PLoS Negl Trop Dis. 2016;10(12):e0005168. doi: 10.1371/journal.pntd.0005168 27911897
39. Dudley DM, Aliota MT, Mohr EL, Weiler AM, Lehrer-Brey G, Weisgrau KL, et al. A rhesus macaque model of Asian-lineage Zika virus infection. Nat Commun. 2016;7:12204. doi: 10.1038/ncomms12204 27352279
40. Osuna CE, Lim SY, Deleage C, Griffin BD, Stein D, Schroeder LT, et al. Zika viral dynamics and shedding in rhesus and cynomolgus macaques. Nat Med. 2016;22(12):1448–55. doi: 10.1038/nm.4206 27694931.
41. Elong Ngono A, Vizcarra EA, Tang WW, Sheets N, Joo Y, Kim K, et al. Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice. Cell Host Microbe. 2017;21(1):35–46. doi: 10.1016/j.chom.2016.12.010 28081442
42. Huang H, Li S, Zhang Y, Han X, Jia B, Liu H, et al. CD8+ T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection. J Virol. 2017. doi: 10.1128/JVI.00900-17 28835502.
43. Sapparapu G, Fernandez E, Kose N, Bin C, Fox JM, Bombardi RG, et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature. 2016;540(7633):443–7. doi: 10.1038/nature20564 27819683.
44. Kucharski AJ, Funk S, Eggo RM, Mallet HP, Edmunds WJ, Nilles EJ, Transmission Dynamics of Zika Virus in Island Populations: A Modelling Analysis of the 2013–14 French Polynesia Outbreak. PLoS Negl Trop Dis. 2016;10(5):e0004726. doi: 10.1371/journal.pntd.0004726 27186984
45. Araujo-Jorge T, Rivera MT, el Bouhdidi A, Daeron M, Carlier Y, An Fc gamma RII-, Fc gamma RIII-specific monoclonal antibody (2.4G2) decreases acute Trypanosoma cruzi infection in mice. Infect Immun. 1993;61(11):4925–8. Epub 1993/11/01. 8406898
46. Kurlander RJ, Ellison DM, Hall J, The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. J Immunol. 1984;133(2):855–62. Epub 1984/08/01. 6736648.
47. Wang S, Hong S, Deng YQ, Ye Q, Zhao LZ, Zhang FC, et al. Transfer of convalescent serum to pregnant mice prevents Zika virus infection and microcephaly in offspring. Cell Res. 2017;27(1):158–60. doi: 10.1038/cr.2016.144 27922617
48. Pardy RD, Rajah MM, Condotta SA, Taylor NG, Sagan SM, Richer MJ, Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice. PLoS Pathog. 2017;13(2):e1006184. doi: 10.1371/journal.ppat.1006184 28231312.
49. Winkler CW, Myers LM, Woods TA, Messer RJ, Carmody AB, McNally KL, et al. Adaptive Immune Responses to Zika Virus Are Important for Controlling Virus Infection and Preventing Infection in Brain and Testes. J Immunol. 2017;198(9):3526–35. doi: 10.4049/jimmunol.1601949 28330900.
50. Lanciotti RS, Lambert AJ, Holodniy M, Saavedra S, Signor Ldel C, Phylogeny of Zika Virus in Western Hemisphere, 2015. Emerg Infect Dis. 2016;22(5):933–5. doi: 10.3201/eid2205.160065 27088323
51. Halstead SB, Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239(4839):476–81. 3277268.
52. Halstead SB, Dengue. Lancet. 2007;370(9599):1644–52. doi: 10.1016/S0140-6736(07)61687-0 17993365.
53. Sabin AB, Research on dengue during World War II. Am J Trop Med Hyg. 1952;1(1):30–50. 14903434.
54. Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith AR, Goo L, et al. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Rep. 2016;16(6):1485–91. doi: 10.1016/j.celrep.2016.07.049 27481466
55. Erlebacher A, Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31:387–411. Epub 2013/01/10. doi: 10.1146/annurev-immunol-032712-100003 23298207.
56. Erlebacher A, Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol. 2013;13(1):23–33. doi: 10.1038/nri3361 23237963.
57. Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney MC, Medits I, Sharma A, et al. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature. 2016;536(7614):48–53. doi: 10.1038/nature18938 27338953.
58. Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016;353(6301):823–6. doi: 10.1126/science.aaf8505 27417494.
59. Zhao H, Fernandez E, Dowd KA, Speer SD, Platt DJ, Gorman MJ, et al. Structural Basis of Zika Virus-Specific Antibody Protection. Cell. 2016;166(4):1016–27. doi: 10.1016/j.cell.2016.07.020 27475895
60. Mehlhop E, Nelson S, Jost CA, Gorlatov S, Johnson S, Fremont DH, et al. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe. 2009;6(4):381–91. doi: 10.1016/j.chom.2009.09.003 19837377
61. Nimmerjahn F, Ravetch JV, Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8(1):34–47. Epub 2007/12/08. doi: 10.1038/nri2206 18064051.
62. Sorman A, Zhang L, Ding Z, Heyman B, How antibodies use complement to regulate antibody responses. Mol Immunol. 2014;61(2):79–88. Epub 2014/07/09. doi: 10.1016/j.molimm.2014.06.010 25001046.
63. George J, Valiant WG, Mattapallil MJ, Walker M, Huang YS, Vanlandingham DL, et al. Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques. Sci Rep. 2017;7(1):10498. Epub 2017/09/07. doi: 10.1038/s41598-017-10901-1 28874759
64. Kawiecki AB, Christofferson RC, Zika Virus-Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro. J Infect Dis. 2016;214(9):1357–60. Epub 2016/08/16. doi: 10.1093/infdis/jiw377 27521359.
65. Schmidt A, Morales-Prieto DM, Pastuschek J, Frohlich K, Markert UR, Only humans have human placentas: molecular differences between mice and humans. J Reprod Immunol. 2015;108:65–71. doi: 10.1016/j.jri.2015.03.001 25817465.
66. Rowe JH, Ertelt JM, Xin L, Way SS, Regulatory T cells and the immune pathogenesis of prenatal infection. Reproduction. 2013;146(6):R191–203. doi: 10.1530/REP-13-0262 23929902
67. Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS, Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe. 2011;10(1):54–64. doi: 10.1016/j.chom.2011.06.005 21767812
68. Chaturvedi V, Ertelt JM, Jiang TT, Kinder JM, Xin L, Owens KJ, et al. CXCR3 blockade protects against Listeria monocytogenes infection-induced fetal wastage. The Journal of Clinical Investigation. 2015;125(4):1713–25. Epub 2015/03/10. doi: 10.1172/JCI78578 25751061
69. Rowe JH, Ertelt JM, Xin L, Way SS, Listeria monocytogenes cytoplasmic entry induces fetal wastage by disrupting maternal FoxP3+ regulatory cell-sustained fetal tolerance. PLoS Pathog. 2012;8(8):e1002873. doi: 10.1371/journal.ppat.1002873 22916020
70. Aliota MT, Caine EA, Walker EC, Larkin KE, Camacho E, Osorio JE, Characterization of Lethal Zika Virus Infection in AG129 Mice. PLoS Negl Trop Dis. 2016;10(4):e0004682. doi: 10.1371/journal.pntd.0004682 27093158
71. Ho HH, Ivashkiv LB, Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem. 2006;281(20):14111–8. Epub 2006/03/31. doi: 10.1074/jbc.M511797200 16571725.
72. Mahmud SA, Manlove LS, Farrar MA, Interleukin-2 and STAT5 in regulatory T cell development and function. JAKSTAT. 2013;2(1):e23154. Epub 2013/09/24. doi: 10.4161/jkst.23154 24058794
73. Kim J, Mohanty S, Ganesan LP, Hua K, Jarjoura D, Hayton WL, et al. FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus. J Immunol. 2009;182(5):2583–9. doi: 10.4049/jimmunol.0803247 19234152
74. Pentsuk N, van der Laan JW, An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res B Dev Reprod Toxicol. 2009;86(4):328–44. doi: 10.1002/bdrb.20201 19626656.
75. Xu C, Mao D, Holers V, Palanca B, Cheng A, Molina H, A critical role for murine complement regulatory Crry in fetomaternal tolerance. Science. 2000;287:498–501. 10642554
76. Tang WW, Young MP, Mamidi A, Regla-Nava JA, Kim K, Shresta S, A Mouse Model of Zika Virus Sexual Transmission and Vaginal Viral Replication. Cell Rep. 2016;17(12):3091–8. doi: 10.1016/j.celrep.2016.11.070 28009279
77. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8):1232–9. doi: 10.3201/eid1408.080287 18680646
78. Muller JA, Harms M, Schubert A, Jansen S, Michel D, Mertens T, et al. Inactivation and Environmental Stability of Zika Virus. Emerg Infect Dis. 2016;22(9):1685–7. Epub 2016/07/02. doi: 10.3201/eid2209.160664 27367466